D.A. Davidson & CO. Sells 4,500 Shares of MiMedx Group, Inc. (NASDAQ:MDXG)

D.A. Davidson & CO. decreased its holdings in shares of MiMedx Group, Inc. (NASDAQ:MDXG) by 3.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 110,900 shares of the company’s stock after selling 4,500 shares during the quarter. D.A. Davidson & CO. owned approximately 0.08% of MiMedx Group worth $1,067,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Principal Financial Group Inc. lifted its stake in shares of MiMedx Group by 8.5% in the fourth quarter. Principal Financial Group Inc. now owns 60,226 shares of the company’s stock worth $579,000 after buying an additional 4,731 shares during the last quarter. Palumbo Wealth Management LLC acquired a new position in MiMedx Group during the 4th quarter worth $171,000. Van ECK Associates Corp bought a new stake in MiMedx Group during the fourth quarter valued at about $40,000. Savant Capital LLC acquired a new stake in shares of MiMedx Group in the fourth quarter valued at about $100,000. Finally, SG Americas Securities LLC increased its stake in shares of MiMedx Group by 79.9% in the fourth quarter. SG Americas Securities LLC now owns 83,385 shares of the company’s stock worth $802,000 after purchasing an additional 37,031 shares during the period. Institutional investors and hedge funds own 79.15% of the company’s stock.

Analyst Ratings Changes

Separately, StockNews.com lowered MiMedx Group from a “strong-buy” rating to a “buy” rating in a report on Friday, November 8th. Six analysts have rated the stock with a buy rating, According to MarketBeat, MiMedx Group has an average rating of “Buy” and an average price target of $12.00.

MiMedx Group Stock Up 1.7 %

MDXG stock opened at $7.98 on Monday. MiMedx Group, Inc. has a twelve month low of $5.47 and a twelve month high of $10.14. The company has a quick ratio of 3.53, a current ratio of 4.10 and a debt-to-equity ratio of 0.10. The company has a market cap of $1.17 billion, a PE ratio of 14.51 and a beta of 1.94. The business’s 50-day simple moving average is $8.84 and its 200 day simple moving average is $7.66.

About MiMedx Group

MiMedx Group, Inc develops and distributes placental tissue allografts for various sectors of healthcare. It processes the human placental tissues utilizing its patented and proprietary PURION process to produce allografts that retains the tissue’s inherent biological properties and regulatory proteins.